Blog

Biogen (NASDAQ: BIIB) recently won approval from the U.S. Food and Drug Administration (FDA) for Alzheimer's disease drug Aduhelm. There was an important catch with this approval, though. In this

Property technology company Latch (NASDAQ: LTCH) recently went public via a special purpose acquisition company (SPAC) merger, and quite frankly, some people are apprehensive about investing in a

These days, a lot of investors are jumping on the cryptocurrency bandwagon. And if you're thinking of adding digital coins to your portfolio, you may have your eye on Bitcoin (CRYPTO: BTC) specifica

Since the end of the Great Recession, growth stocks have pretty much left everything else eating their dust. But pan out over the very long-term and you'll see that dividend stocks are the real

Investing using options is very different from constructing a classic long-term buy-and-hold portfolio. 

In this segment from Motley Fool Live that first aired June 7, Motley Fool Canada analyst Jim

There are few industries that have more potential to be disrupted than real estate, and that's exactly why Redfin (NASDAQ: RDFN) is on the radar of some of our experts. In this Fool Live video

Investing using options is very different from constructing a classic long-term buy-and-hold portfolio. 

In this segment from Motley Fool Live that first aired June 7, Motley Fool Canada analyst Jim

Media discussion about newly approved Alzheimer's disease treatment Aduhelm (aducanumab) has focused much attention on its high price tag and questionable efficacy. But the drug, which was developed

For more than a century, the stock market has stood atop the pedestal among other investment vehicles. Though there have been years where bonds, oil, and even gold have outperformed the benchmark

You might not have heard of Ocugen (NASDAQ: OCGN) a year ago. Shares of the biotech company traded for less than a dollar. And Ocugen focused uniquely on its investigational treatments for eye

It might seem that Warren Buffett doesn't like dividends. After all, Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) has never paid a dividend. Even with the company sitting on a cash stockpile of

Investors hum to the tune of Fleetwood Mac's "Don't Stop" (the lyrics go further -- "don't stop thinking about tomorrow") a lot more than they do to "Auld Lang Syne." The future is more important

Arguably the most important lesson investors learn when putting their money to work in the stock market is that patience pays off.

Last year, the coronavirus pandemic sent the widely tracked S&P 500

Retirement isn't the sort of thing you should just dive into. In fact, you should really spend most of your working life planning for that milestone, and that includes saving steadily, investing

Warren Buffett famously said to be greedy when others are fearful. Putting that mantra to work netted him tens of billions of dollars during the Great Financial Crisis. As individual investors, we

As the largest owner and operator of diagnostic imaging centers in the U.S., RadNet (NASDAQ: RDNT) is a one-stop-shop for medical imaging. Providing X-rays, ultrasounds, CT scans, and MRIs, the

At some point along the way, the vast encyclopedia of corny jokes handed down through the ages became dad jokes. But hey, who's complaining -- you know you love them. Or at least get a mild chuckle

The race is on among pharmaceutical companies to obtain approval from the U.S. Food and Drug Administration (FDA) for new products serving the atopic dermatitis (AD, otherwise known as severe and

Biogen (NASDAQ: BIIB) has been quite busy lately. The biotech won U.S. Food and Drug Administration (FDA) approval for its Alzheimer's disease drug Aduhelm. Soon afterward, Biogen announced two

Renewable energy is a massive, multi-decade megatrend. Current estimates suggest that the global economy will require $100 trillion of investments over the next 30 years to switch power sources from

Biogen (NASDAQ: BIIB) stock skyrocketed after its Alzheimer's disease drug Aduhelm won U.S. Food and Drug Administration (FDA) approval. In this Motley Fool Live video recorded on June 9, Motley

E-commerce is among the most compelling and lucrative secular growth stories in the world. Even after the pandemic meaningfully accelerated the space's overall demand, the category is still set to

In this video, I will be talking about NVIDIA (NASDAQ: NVDA) and why I believe it will become the next trillion-dollar company, and potentially one of the world's biggest and most important

One major catalyst for streaming-TV platform Roku (NASDAQ: ROKU) that has been gaining traction lately is its Roku Channel -- a streaming service dead set on capitalizing on compelling market trends

When it comes to saving for retirement, the 401(k) is a fantastic option. Not everyone has access to a 401(k), but if your employer offers this type of account, it's wise to take advantage of it.